Igls, Austria

Gerhard Puerstinger

This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: K.u. Leuven Research & Development, Gilead Sciences, Inc., Other. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Puerstinger. Retrieved from https://idiyas.com/inventor/gerhard-puerstinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gerhard Puerstinger: Innovator in Viral Inhibitors

Introduction

Gerhard Puerstinger is a notable inventor based in Igls, Austria. He has made significant contributions to the field of viral inhibitors, holding a total of 4 patents. His work focuses on developing compounds that are useful in the prophylaxis or treatment of viral infections.

Latest Patents

Puerstinger's latest patents include innovative compounds known as Pyrrolo[2,3-c]pyridine or pyrrolo[3,2-c]pyridine. These compounds have a general formula (A), wherein the dashed lines, X, Y, and R through R are defined in the specification. The compounds are designed to be effective in preventing or treating viral infections.

Career Highlights

Throughout his career, Puerstinger has worked with various research institutions, including K.U. Leuven Research & Development. His expertise in the field of viral inhibitors has positioned him as a key figure in the development of new therapeutic options.

Collaborations

Some of his notable coworkers include David A. Oare and Steven S. Bondy. Their collaborative efforts have contributed to the advancement of research in viral inhibitors.

Conclusion

Gerhard Puerstinger's innovative work in the field of viral inhibitors showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…